Order Now, Ships Today
One-time
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
BPC + TB is a research-only peptide blend that combines two well-known synthetic fragments: BPC-157 (a gastric-derived peptide) and TB-500 (a fragment related to thymosin beta-4). It is supplied as a lyophilized powder for reconstitution and use in controlled in-vitro and in-vivo experimental models, typically in studies of tissue repair, extracellular matrix dynamics and angiogenesis. This material is not approved for human use and is sold strictly for laboratory research.
Each lot of BPC + TB is released at high purity (commonly ≥98–99%) verified by HPLC and/or LC-MS. The accompanying Certificate of Analysis usually documents: Identity of BPC-157 and TB-500 (mass spec / peptide mapping) Purity profile and chromatograms for each component Peptide content per vial (total mg and mg of each component as specified by the manufacturer) Appearance (white to off-white lyophilized powder) Residual solvent and moisture content within internal limits All labeling is “for research use only, not for human consumption.”
Products from Elite Miami Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.
Each vial contains exactly what’s indicated on the label. For instance, a 10mg vial contains precisely 10mg of lyophilized peptide. Researchers may divide it into smaller research portions—such as four 2.5mg aliquots—but the total content remains the same.
Yes. All peptides are supplied in lyophilized powder form and do not come reconstituted. Any extra materials required for research, such as solvents or diluents, must be obtained separately.
When stored as a dry powder, peptides remain stable for up to 2 years.
Once reconstituted, the solution should be kept refrigerated and is typically stable for up to 2 months under proper storage conditions.
Individually, BPC-157 and TB-500 have been widely used as tool peptides in preclinical models: BPC-157 has been explored in gastrointestinal, tendon, ligament and soft-tissue models, with reported effects on angiogenic markers, fibroblast activity, nitric-oxide pathways and tissue integrity. TB-500 (a thymosin beta-4–related fragment) is often used to study cell migration, actin cytoskeleton dynamics, wound healing and anti-fibrotic signalling in cardiac, corneal, dermal and musculoskeletal systems. As a combined formulation, BPC + TB provides researchers with a single vial to probe overlapping and potentially complementary pathways related to tissue repair, microvascular remodeling and matrix regulation.
In simple terms, BPC + TB is a “two-in-one” lab peptide vial. Instead of testing BPC-157 and TB-500 separately, scientists can look at what happens when both are present at the same time in their experiments. Typical research questions involve how quickly cells move, how well they rebuild collagen and other matrix components, how new blood-vessel markers behave, and how damaged tissues respond in controlled models. It is not a medicine, not a supplement and is meant only for carefully designed lab research.
⚠️ Disclaimer: this product is not approved for medical use and is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and research purposes only, and this product must never be used in humans or animals.
BPC-157 and thymosin-beta-4–related peptides were first investigated separately across different repair-oriented models. Over time, as both gained popularity as tool compounds in soft-tissue and cardiovascular research, suppliers began offering fixed-blend vials (BPC + TB) so investigators could study possible additive or synergistic effects without managing two separate peptide stocks. Most of the peer-reviewed data still come from work on each component individually; use of the specific blend is newer and largely catalog-driven.
BPC + TB is a mixture, not a single peptide: BPC-157 – a 15-amino-acid peptide fragment derived from “body protection compound”; frequently cited formula around C₆₂H₉₈N₁₆O₂₂ (salt form may vary by manufacturer). TB-500 – a peptide fragment based on thymosin beta-4 that contains the characteristic LKKTET actin-binding motif. Sequence length and exact formula depend on the specific commercial TB-500 fragment used. The two peptides are co-lyophilized in one vial and retain their own primary sequences and molecular weights; no covalent linkage between them is implied.
From studies on the individual components: BPC-157 has been reported to modulate angiogenesis-related factors, support fibroblast function, influence nitric-oxide signalling and improve macroscopic and histologic tissue scores in various tendon, ligament, muscle and gastrointestinal models. TB-500 / thymosin-beta-4–related fragments have been associated with enhanced cell migration, cytoskeletal reorganization, reduced fibrosis and improved structural and functional outcomes in cardiac, dermal, corneal and musculoskeletal injury models. When combined, BPC + TB is used in exploratory work to examine whether simultaneous exposure shifts readouts such as wound-closure rate, matrix composition, microvascular density and inflammatory profiles more than either peptide alone. Data on the exact commercial blend are still limited and model-dependent.
Practically, labs choose BPC + TB when they want to “hit” several repair-related pathways at once instead of running separate BPC-157 and TB-500 experiments. Early findings with the individual peptides are promising in cell and animal studies, but this remains experimental science. Current results do not establish safety or effectiveness for any condition in humans, and BPC + TB should be treated strictly as a research chemical, handled under appropriate laboratory and regulatory procedures.
– Experimental and review articles describing BPC-157 in gastrointestinal and musculoskeletal repair models. – Preclinical work on thymosin beta-4 and TB-500 fragments in cardiac, dermal, corneal and soft-tissue wound-healing models. – Supplier and catalog materials on BPC + TB combination vials used as multi-pathway repair tool compounds in research.
Delta Sleep-Inducing (DSIP)
Our specialists respond within minutes to any order or product inquiry.
These products are for laboratory research only and not intended for medical use. They are not FDA-approved to diagnose, treat, cure, or prevent any disease. By purchasing, you certify they will be used solely for research and not for human or animal consumption.
By clicking the button above, you agree to receive marketing text messages from Elite Miami Peptides at the number provided. Consent is not a condition of purchase. Msg & data rates may apply. Reply STOP to cancel, HELP for help. View our Privacy Policy.
All compounds from Elite Miami Peptides are intended strictly for laboratory research purposes.
They are not for human use, consumption, or therapeutic applications.
Products are supplied exclusively to qualified professionals working in compliance with all applicable laws and regulations.
